查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1786563

乳房切片市場：全球產業分析、規模、佔有率、成長、趨勢與預測（2025-2032）

Breast Biopsy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 198 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 最近發布了一份關於全球乳房切片設備市場的綜合報告，本報告徹底評估了重要市場動態，包括市場促進因素、趨勢、機會和挑戰，並對市場結構提供了詳細的見解。

關鍵見解

  • 乳房切片市場規模（2025年）：24.659億美元
  • 市場預測（2032年）：35.871億美元
  • 全球市場成長率（2025-2032年年複合成長率）：5.5%

乳房切片市場 - 研究範圍

乳房切片是一項重要的診斷程序，用於評估可疑的乳房異常，並確認或排除乳癌的存在。操作程序包括芯針活體組織切片、真空輔助切片檢查和細針穿刺，這些活體組織切片均在超音波、立體定位系統和核磁共振成像（MRI）等顯像模式的引導下進行。市場為醫院、診斷中心和門診手術中心提供從針吸活體組織切片設備到先進影像導引系統等各種設備。市場成長的驅動力包括：全球乳癌發生率的上升、人們對早期癌症檢測意識的增強，以及減少患者不適和縮短恢復時間的微創手術的普及。

市場成長動力：

全球乳房切片市場受乳癌是全球女性癌症相關死亡的主要原因之一。對常規篩檢和早期診斷的日益重視，推動了對精準微創切片檢查技術的需求。即時3D影像和機器人輔助切片檢查設備等技術進步提高診斷準確性和操作效率，進一步推動市場成長。此外，已開發經濟體和新興經濟體政府紛紛推出支持乳癌認知和篩檢計畫的舉措，也促進了乳房切片市場的廣泛應用。

市場限制：

儘管乳房切片市場成長動力強勁，但仍面臨著許多挑戰，例如高昂的手術費用以及低收入地區取得乳房切片服務的管道受限。某些切片檢查程序的侵入性以及患者對流程的焦慮可能會阻礙其普及，尤其是在醫療基礎設施有限的地區。此外，監管部門對新型切片檢查系統的嚴格核准以及對某些程序假陰性結果的擔憂，可能會影響市場信心，並減緩先進技術的普及。解決這些問題需要整個產業致力於創新、可負擔性和病患教育。

市場機會：

乳房切片市場蘊藏著豐厚的機會，這得益於人工智慧輔助診斷、智慧成像系統以及適用於偏遠和資源匱乏環境的攜帶式切片檢查設備等技術的整合。私人和公共醫療機構不斷擴大對癌症治療基礎設施的投資，尤其是在亞太地區和拉丁美洲，開闢新的成長途徑。此外，門診和家庭診斷的趨勢預計將推動對緊湊易用的切片檢查系統的需求。與醫療保健提供者、研究機構和數位健康平台建立策略合作夥伴關係，可以增強產品供應並提高市場滲透率。

本報告探討的關鍵問題

  • 推動全球乳房切片市場成長的主要因素有哪些？
  • 在不同的臨床環境下，哪種切片檢查類型和影像方式是首選？
  • 診斷影像和設備小型化的技術進步如何改變市場格局？
  • 乳房切片市場的主要企業是誰？他們採取哪些策略措施？
  • 哪些新興趨勢和機會將決定乳房切片技術的未來？

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍和定義
  • 價值鏈分析
  • 宏觀經濟因素
    • 世界GDP展望
    • 世界GDP展望
    • 全球經濟成長預測
    • 全球都市化進程
    • 其他宏觀經濟因素
  • 預測因子 - 相關性和影響力
  • COVID-19影響評估
  • PESTLE分析
  • 波特五力分析
  • 地緣政治緊張局勢：市場影響
  • 監管和技術格局

第3章 市場動態

  • 促進因素
  • 抑制因素
  • 機會
  • 趨勢

第4章 2019-2032年價格趨勢分析

  • 區域價格分析
  • 依細分市場定價
  • 價格影響因素

第5章 全球乳房切片市場展望：實際（2019-2024年）和預測（2025-2032年）

  • 主要亮點
  • 全球乳房切片市場展望：產品
    • 簡介/主要調查結果
    • 2019-2024年市場規模趨勢分析：依產品
    • 2025-2032年當前市場規模預測：依產品
      • 切片穿刺針
        • 粗針切片
        • 細吸針
      • MRI導引切片檢查系統
      • 超音波引導乳房切片系統
        • 2D（2D）乳房X光攝影超音波掃描系統
        • 3D（3D）B型乳房X光攝影超音波掃描系統
      • 真空輔助裝置（VAD）
      • 導管導引線（定位絲）
      • 乳房切片標記物
    • 市場吸引力分析：產品
  • 全球乳房切片市場展望：適應症
    • 簡介/主要調查結果
    • 2019-2024年市場規模趨勢分析：依適應症
    • 2025-2032年當前市場規模預測：依適應症
      • 複雜囊腫
      • 固體塊
      • 可疑固態腫塊（纖維腺瘤）
      • 可疑微鈣化
    • 市場吸引力分析：跡象
  • 全球乳房切片市場展望：最終用戶
    • 簡介/主要調查結果
    • 2019-2024年市場規模趨勢分析：依最終用戶
    • 2025-2032年當前市場規模預測：依最終用戶
      • 醫院
      • 專科診所
      • 門診手術中心
      • 癌症研究所
    • 市場吸引力分析：最終用戶

第6章 全球乳房切片市場展望：依地區

  • 主要亮點
  • 2019-2024年市場規模趨勢分析：依地區
  • 2025-2032年目前市場規模預測：依地區
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：地區

第7章 北美乳房切片市場展望：實績（2019-2024年）和預測（2025-2032年）

第8章 歐洲乳房切片市場展望：實績（2019-2024年）與預測（2025-2032年）

第9章 東亞乳房切片市場展望：實績（2019-2024年）和預測（2025-2032年）

第10章 南亞和大洋洲乳房切片市場展望：實績（2019-2024年）和預測（2025-2032年）

第11章 拉丁美洲乳房切片市場展望：實績（2019-2024年）和預測（2025-2032年）

第12章 中東和非洲乳房切片市場展望：實績（2019-2024年）和預測（2025-2032年）

第13章 競爭格局

  • 2025年市場佔有率分析
  • 市場結構
    • 競爭強度圖
    • 競爭儀表板
  • 公司簡介
    • Argon Medical
    • Becton Dickinson and Company
    • CR Bard, Inc.
    • Cook Medical Inc.
    • Devicor Medical Products, Inc.
    • F. Hoffmann-La Roche Ltd.,
    • GE Healthcare
    • Hologic, Inc.
    • Leica Biosystems
    • Medax Srl Unipersonale
    • Planmed Oy
    • Scion Medical Technologies, LLC
    • Siemens Healthineers
    • Hikma Pharmaceuticals
    • Incytes

第14章 附錄

  • 調查方法
  • 調查前提
  • 首字母縮寫和簡稱
簡介目錄
Product Code: PMRREP33464

Persistence Market Research has recently released a comprehensive report on the worldwide market for breast biopsy devices. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Breast Biopsy Market Size (2025E): USD 2,465.9 Million
  • Projected Market Value (2032F): USD 3,587.1 Million
  • Global Market Growth Rate (CAGR 2025 to 2032): 5.5%

Breast Biopsy Market - Report Scope:

Breast biopsy is a critical diagnostic procedure employed to evaluate suspicious breast abnormalities and confirm or rule out the presence of breast cancer. Techniques include core needle biopsy, vacuum-assisted biopsy, and fine needle aspiration, guided by imaging modalities such as ultrasound, stereotactic systems, and MRI. The market serves hospitals, diagnostic centers, and ambulatory surgical centers with devices ranging from needle-based biopsy instruments to advanced imaging-guided systems. Market growth is driven by the rising global incidence of breast cancer, increased awareness about early cancer detection, and the adoption of minimally invasive procedures that reduce patient discomfort and recovery time.

Market Growth Drivers:

The global breast biopsy market is propelled by the rising prevalence of breast cancer, one of the leading causes of cancer-related deaths among women globally. Increased emphasis on routine screening and early diagnosis has boosted the demand for accurate and minimally invasive biopsy techniques. Technological advancements, including real-time 3D imaging and robotic-assisted biopsy devices, enhance diagnostic accuracy and procedural efficiency, further driving market growth. Additionally, government initiatives supporting breast cancer awareness and screening programs in both developed and emerging economies contribute to broader market adoption.

Market Restraints:

Despite its strong growth trajectory, the breast biopsy market faces challenges such as high procedural costs and limited accessibility in low-income regions. Invasive nature of some biopsy procedures and patient anxiety regarding the process can hinder adoption, particularly in settings with limited healthcare infrastructure. Moreover, stringent regulatory approvals for new biopsy systems and concerns regarding false-negative results in certain techniques may impact market confidence and slow adoption of advanced technologies. Addressing these issues requires industry-wide focus on innovation, affordability, and patient education.

Market Opportunities:

The breast biopsy market presents lucrative opportunities through technological integration, such as AI-based diagnostic support tools, smart imaging systems, and portable biopsy devices for use in remote and resource-constrained settings. Expanding private and public healthcare investments in cancer care infrastructure, especially in Asia Pacific and Latin America, opens new growth avenues. Furthermore, the trend toward outpatient and home-based diagnostic procedures is expected to stimulate demand for compact and user-friendly biopsy systems. Strategic collaborations with healthcare providers, research institutions, and digital health platforms can enhance product offerings and increase market penetration.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the breast biopsy market globally?
  • Which biopsy types and imaging modalities are preferred across various clinical settings?
  • How are innovations in imaging and device miniaturization reshaping the market landscape?
  • Who are the key players in the breast biopsy market, and what strategic initiatives are they pursuing?
  • What emerging trends and opportunities are expected to define the future of breast biopsy technologies?

Competitive Intelligence and Business Strategy:

These companies invest heavily in R\&D to develop next-generation biopsy tools with enhanced precision, speed, and patient comfort. Collaborative efforts with imaging solution providers and research hospitals aim to integrate AI and machine learning for improved diagnostic outcomes. Market leaders also focus on regulatory approvals, clinical validation, and physician training programs to drive adoption and maintain competitive advantage.

Key Companies Profiled:

  • Argon Medical Devices
  • Becton Dickinson and Company
  • C. R. Bard, Inc.
  • Cook Medical Inc.
  • Devicor Medical Products, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Hologic, Inc.
  • Leica Biosystems
  • Medax Srl Unipersonale
  • Planmed Oy
  • Scion Medical Technologies, LLC
  • Siemens Healthineer

Breast Biopsy Market Research Segmentation:

Product:

  • Biopsy Needles
    • * Core Needles
    • * Fine Aspiration Needles
  • MRI-Guide Biopsy Systems
  • Ultrasound Guided Breast Biopsy Systems
    • * Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
    • * Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
  • Vacuum-Assisted Devices (VAD)
  • Guide Wire (Localization Wire)
  • Breast Biopsy Markers

Indication:

  • Complex Cysts
  • Solid Mass
  • Suspicious Solid Mass (Fibroadenoma)
  • Suspicious Micro-calcifications

End User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Cancer Research Institutes

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Breast Biopsy Market Snapshot 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Industry Developments and Key Market Events
  • 1.5. Demand Side and Supply Side Analysis
  • 1.6. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definitions
  • 2.2. Value Chain Analysis
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Outlook
    • 2.3.2. Global GDP Outlook
    • 2.3.3. Global economic Growth Forecast
    • 2.3.4. Global Urbanization Growth
    • 2.3.5. Other Macro-economic Factors
  • 2.4. Forecast Factors - Relevance and Impact
  • 2.5. COVID-19 Impact Assessment
  • 2.6. PESTLE Analysis
  • 2.7. Porter's Five Forces Analysis
  • 2.8. Geopolitical Tensions: Market Impact
  • 2.9. Regulatory and Technology Landscape

3. Market Dynamics

  • 3.1. Drivers
  • 3.2. Restraints
  • 3.3. Opportunities
  • 3.4. Trends

4. Price Trend Analysis, 2019-2032

  • 4.1. Region-wise Price Analysis
  • 4.2. Price by Segments
  • 4.3. Price Impact Factors

5. Global Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 5.1. Key Highlights
  • 5.2. Global Breast Biopsy Market Outlook: Product
    • 5.2.1. Introduction/Key Findings
    • 5.2.2. Historical Market Size (US$ Mn) Analysis by Product, 2019-2024
    • 5.2.3. Current Market Size (US$ Mn) Forecast, by Product, 2025-2032
      • 5.2.3.1. Biopsy Needles
        • 5.2.3.1.1. Core Needles
        • 5.2.3.1.2. Fine Aspiration Needles
      • 5.2.3.2. MRI-Guide Biopsy Systems
      • 5.2.3.3. Ultrasound Guided Breast Biopsy Systems
        • 5.2.3.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
        • 5.2.3.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
      • 5.2.3.4. Vacuum-Assisted Devices (VAD)
      • 5.2.3.5. Guide Wire (Localization Wire)
      • 5.2.3.6. Breast Biopsy Markers
    • 5.2.4. Market Attractiveness Analysis: Product
  • 5.3. Global Breast Biopsy Market Outlook: Indication
    • 5.3.1. Introduction/Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) Analysis by Indication, 2019-2024
    • 5.3.3. Current Market Size (US$ Mn) Forecast, by Indication, 2025-2032
      • 5.3.3.1. Complex Cysts
      • 5.3.3.2. Solid Mass
      • 5.3.3.3. Suspicious Solid Mass (Fibroadenoma)
      • 5.3.3.4. Suspicious Micro-calcifications
    • 5.3.4. Market Attractiveness Analysis: Indication
  • 5.4. Global Breast Biopsy Market Outlook: End User
    • 5.4.1. Introduction/Key Findings
    • 5.4.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2024
    • 5.4.3. Current Market Size (US$ Mn) Forecast, by End User, 2025-2032
      • 5.4.3.1. Hospitals
      • 5.4.3.2. Specialty Clinics
      • 5.4.3.3. Ambulatory Surgical Centers
      • 5.4.3.4. Cancer Research Institutes
    • 5.4.4. Market Attractiveness Analysis: End User

6. Global Breast Biopsy Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2024
  • 6.3. Current Market Size (US$ Mn) Forecast, by Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia & Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. North America Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. North America Market Size (US$ Mn) Forecast, by Product, 2025-2032
    • 7.4.1. Biopsy Needles
      • 7.4.1.1. Core Needles
      • 7.4.1.2. Fine Aspiration Needles
    • 7.4.2. MRI-Guide Biopsy Systems
    • 7.4.3. Ultrasound Guided Breast Biopsy Systems
      • 7.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
      • 7.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
    • 7.4.4. Vacuum-Assisted Devices (VAD)
    • 7.4.5. Guide Wire (Localization Wire)
    • 7.4.6. Breast Biopsy Markers
  • 7.5. North America Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 7.5.1. Complex Cysts
    • 7.5.2. Solid Mass
    • 7.5.3. Suspicious Solid Mass (Fibroadenoma)
    • 7.5.4. Suspicious Micro-calcifications
  • 7.6. North America Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Specialty Clinics
    • 7.6.3. Ambulatory Surgical Centers
    • 7.6.4. Cancer Research Institutes

8. Europe Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Europe Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. Italy
    • 8.3.3. France
    • 8.3.4. U.K.
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Rest of Europe
  • 8.4. Europe Market Size (US$ Mn) Forecast, by Product, 2025-2032
    • 8.4.1. Biopsy Needles
      • 8.4.1.1. Core Needles
      • 8.4.1.2. Fine Aspiration Needles
    • 8.4.2. MRI-Guide Biopsy Systems
    • 8.4.3. Ultrasound Guided Breast Biopsy Systems
      • 8.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
      • 8.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
    • 8.4.4. Vacuum-Assisted Devices (VAD)
    • 8.4.5. Guide Wire (Localization Wire)
    • 8.4.6. Breast Biopsy Markers
  • 8.5. Europe Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 8.5.1. Complex Cysts
    • 8.5.2. Solid Mass
    • 8.5.3. Suspicious Solid Mass (Fibroadenoma)
    • 8.5.4. Suspicious Micro-calcifications
  • 8.6. Europe Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Specialty Clinics
    • 8.6.3. Ambulatory Surgical Centers
    • 8.6.4. Cancer Research Institutes

9. East Asia Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. East Asia Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. East Asia Market Size (US$ Mn) Forecast, by Product, 2025-2032
    • 9.4.1. Biopsy Needles
      • 9.4.1.1. Core Needles
      • 9.4.1.2. Fine Aspiration Needles
    • 9.4.2. MRI-Guide Biopsy Systems
    • 9.4.3. Ultrasound Guided Breast Biopsy Systems
      • 9.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
      • 9.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
    • 9.4.4. Vacuum-Assisted Devices (VAD)
    • 9.4.5. Guide Wire (Localization Wire)
    • 9.4.6. Breast Biopsy Markers
  • 9.5. East Asia Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 9.5.1. Complex Cysts
    • 9.5.2. Solid Mass
    • 9.5.3. Suspicious Solid Mass (Fibroadenoma)
    • 9.5.4. Suspicious Micro-calcifications
  • 9.6. East Asia Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Specialty Clinics
    • 9.6.3. Ambulatory Surgical Centers
    • 9.6.4. Cancer Research Institutes

10. South Asia & Oceania Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. South Asia & Oceania Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of SAO
  • 10.4. South Asia & Oceania Market Size (US$ Mn) Forecast, by Product, 2025-2032
    • 10.4.1. Biopsy Needles
      • 10.4.1.1. Core Needles
      • 10.4.1.2. Fine Aspiration Needles
    • 10.4.2. MRI-Guide Biopsy Systems
    • 10.4.3. Ultrasound Guided Breast Biopsy Systems
      • 10.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
      • 10.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
    • 10.4.4. Vacuum-Assisted Devices (VAD)
    • 10.4.5. Guide Wire (Localization Wire)
    • 10.4.6. Breast Biopsy Markers
  • 10.5. South Asia & Oceania Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 10.5.1. Complex Cysts
    • 10.5.2. Solid Mass
    • 10.5.3. Suspicious Solid Mass (Fibroadenoma)
    • 10.5.4. Suspicious Micro-calcifications
  • 10.6. South Asia & Oceania Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Specialty Clinics
    • 10.6.3. Ambulatory Surgical Centers
    • 10.6.4. Cancer Research Institutes

11. Latin America Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Latin America Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of LATAM
  • 11.4. Latin America Market Size (US$ Mn) Forecast, by Product, 2025-2032
    • 11.4.1. Biopsy Needles
      • 11.4.1.1. Core Needles
      • 11.4.1.2. Fine Aspiration Needles
    • 11.4.2. MRI-Guide Biopsy Systems
    • 11.4.3. Ultrasound Guided Breast Biopsy Systems
      • 11.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
      • 11.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
    • 11.4.4. Vacuum-Assisted Devices (VAD)
    • 11.4.5. Guide Wire (Localization Wire)
    • 11.4.6. Breast Biopsy Markers
  • 11.5. Latin America Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 11.5.1. Complex Cysts
    • 11.5.2. Solid Mass
    • 11.5.3. Suspicious Solid Mass (Fibroadenoma)
    • 11.5.4. Suspicious Micro-calcifications
  • 11.6. Latin America Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Specialty Clinics
    • 11.6.3. Ambulatory Surgical Centers
    • 11.6.4. Cancer Research Institutes

12. Middle East & Africa Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 12.1. Key Highlights
  • 12.2. Pricing Analysis
  • 12.3. Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. South Africa
    • 12.3.3. Northern Africa
    • 12.3.4. Rest of MEA
  • 12.4. Middle East & Africa Market Size (US$ Mn) Forecast, by Product, 2025-2032
    • 12.4.1. Biopsy Needles
      • 12.4.1.1. Core Needles
      • 12.4.1.2. Fine Aspiration Needles
    • 12.4.2. MRI-Guide Biopsy Systems
    • 12.4.3. Ultrasound Guided Breast Biopsy Systems
      • 12.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
      • 12.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
    • 12.4.4. Vacuum-Assisted Devices (VAD)
    • 12.4.5. Guide Wire (Localization Wire)
    • 12.4.6. Breast Biopsy Markers
  • 12.5. Middle East & Africa Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 12.5.1. Complex Cysts
    • 12.5.2. Solid Mass
    • 12.5.3. Suspicious Solid Mass (Fibroadenoma)
    • 12.5.4. Suspicious Micro-calcifications
  • 12.6. Middle East & Africa Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 12.6.1. Hospitals
    • 12.6.2. Specialty Clinics
    • 12.6.3. Ambulatory Surgical Centers
    • 12.6.4. Cancer Research Institutes

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles
    • 13.3.1. Argon Medical
      • 13.3.1.1. Company Overview
      • 13.3.1.2. Product Portfolio/Offerings
      • 13.3.1.3. Key Financials
      • 13.3.1.4. SWOT Analysis
      • 13.3.1.5. Company Strategy and Key Developments
    • 13.3.2. Becton Dickinson and Company
    • 13.3.3. C.R. Bard, Inc.
    • 13.3.4. Cook Medical Inc.
    • 13.3.5. Devicor Medical Products, Inc.
    • 13.3.6. F. Hoffmann-La Roche Ltd.,
    • 13.3.7. GE Healthcare
    • 13.3.8. Hologic, Inc.
    • 13.3.9. Leica Biosystems
    • 13.3.10. Medax Srl Unipersonale
    • 13.3.11. Planmed Oy
    • 13.3.12. Scion Medical Technologies, LLC
    • 13.3.13. Siemens Healthineers
    • 13.3.14. Hikma Pharmaceuticals
    • 13.3.15. Incytes

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations